Table 2. Concordance of genital HPV DNA and antibody positivity in paired genital specimens and sera from individual participants stratified by gender in rural Anyang, 2007–2009.
| Gender | HPV type | DNA+ | Antibody+ | DNA+ and antibody+ | DNA+ and antibody- | DNA- and antibody+ | DNA+ and/or antibody+ | DNA- and antibody- |
|---|---|---|---|---|---|---|---|---|
| No. (%) | ||||||||
| Male (n = 1603) | ||||||||
| Any HPV (n = 10) | 176 (11.0) | 1068 (66.6) | 106 (6.6) | 70 (4.4) | 962 (60.0) | 1138 (71.0) | 465 (29.0) | |
| Oncogenic HPV (n = 5) | 80 (5.0) | 497 (31.0) | 22 (1.4) | 58 (3.6) | 475 (29.6) | 555 (34.6) | 1048 (65.4) | |
| HPV-16 | 45 (2.8) | 167 (10.4) | 4 (0.3) | 41 (2.6) | 163 (10.2) | 208 (13.0) | 1395 (87.0) | |
| HPV-18 | 18 (1.1) | 146 (9.1) | 1 (0.1) | 17 (1.1) | 145 (9.1) | 163 (10.2) | 1440 (89.8) | |
| HPV-45 | 3 (0.2) | 104 (6.5) | 0 (0.0) | 3 (0.2) | 104 (6.5) | 107 (6.7) | 1496 (93.3) | |
| HPV-52 | 3 (0.2) | 84 (5.2) | 1 (0.1) | 2 (0.1) | 83 (5.2) | 86 (5.4) | 1517 (94.6) | |
| HPV-58 | 11 (0.7) | 155 (9.7) | 3 (0.2) | 8 (0.5) | 152 (9.5) | 163 (10.2) | 1440 (89.8) | |
| Non-oncogenic HPV (n = 5) | 96 (6.0) | 902 (56.3) | 44 (2.7) | 52 (3.2) | 858 (53.5) | 954 (59.5) | 649 (40.5) | |
| HPV-3 | 49 (3.1) | 353 (22.0) | 12 (0.8) | 37 (2.3) | 341 (21.2) | 390 (24.3) | 1213 (75.7) | |
| HPV-6 | 4 (0.3) | 368 (23.0) | 1 (0.1) | 3 (0.2) | 367 (22.9) | 371 (23.1) | 1232 (76.9) | |
| HPV-11 | 12 (0.8) | 227 (14.2) | 1 (0.1) | 11 (0.7) | 226 (14.1) | 238 (14.8) | 1365 (85.2) | |
| HPV-57 | 22 (1.4) | 154 (9.6) | 4 (0.3) | 18 (1.1) | 150 (9.4) | 172 (10.7) | 1431 (89.3) | |
| HPV-75 | 9 (0.6) | 355 (22.1) | 1 (0.1) | 8 (0.5) | 354 (22.1) | 363 (22.6) | 1240 (77.4) | |
| Female (n = 2187) | ||||||||
| Any HPV (n = 10) | 109 (5.0) | 1386 (63.4) | 68 (3.1) | 41 (1.9) | 1318 (60.3) | 1427 (65.2) | 760 (34.8) | |
| Oncogenic HPV (n = 5) | 77 (3.5) | 631 (28.9) | 26 (1.2) | 51 (2.3) | 605 (27.7) | 682 (31.2) | 1505 (68.8) | |
| HPV-16 | 48 (2.2) | 210 (9.6) | 6 (0.3) | 42 (1.9) | 212 (9.2) | 260 (11.9) | 1935 (88.5) | |
| HPV-18 | 2 (0.1) | 192 (8.8) | 0 (0.0) | 2 (0.1) | 192 (8.8) | 194 (8.9) | 1993 (91.1) | |
| HPV-45 | 4 (0.2) | 155 (7.1) | 1 (0.1) | 3 (0.1) | 154 (7.0) | 158 (7.2) | 2029 (92.8) | |
| HPV-52 | 8 (0.4) | 76 (3.5) | 1 (0.1) | 7 (0.3) | 75 (3.4) | 83 (3.8) | 2104 (96.2) | |
| HPV-58 | 15 (0.7) | 229 (10.5) | 3 (0.1) | 12 (0.6) | 226 (10.3) | 241 (11.0) | 1946 (89.0) | |
| Non-oncogenic HPV (n = 5) | 32 (1.5) | 1133 (51.8) | 19 (0.8) | 13 (0.6) | 1114 (50.9) | 1146 (52.4) | 1041 (47.6) | |
| HPV-3 | 26 (1.2) | 440 (20.1) | 8 (0.4) | 18 (0.8) | 432 (19.8) | 458 (20.9) | 1729 (79.1) | |
| HPV-6 | 2 (0.1) | 427 (19.5) | 1 (0.1) | 1 (0.1) | 426 (19.5) | 428 (19.6) | 1759 (80.4) | |
| HPV-11 | 0 (0.0) | 316 (14.5) | 0 (0.0) | 0 (0.0) | 316 (14.5) | 316 (14.5) | 1871 (85.6) | |
| HPV-57 | 4 (0.2) | 207 (9.5) | 1 (0.1) | 3 (0.1) | 206 (9.4) | 210 (9.6) | 1977 (90.4) | |
| HPV-75 | 0 (0.0) | 484 (22.1) | 0 (0.0) | 0 (0.0) | 484 (22.1) | 484 (22.1) | 1703 (77.9) | |
“DNA+” denotes positive for HPV DNA; “DNA-” denotes negative for HPV DNA; “antibody+” denotes positive for HPV antibody; “antibody-” denotes negative for HPV antibody.
Abbreviation: HPV, human papillomavirus.